Over the last decade, articles describing the identifi cation of linkage markers, and indeed the genes responsible, for diseases have filled the journals, and fields as diverse as haematology and cancer research have been quite transformed (Weatherall, 1985) . Recombinant DNA technologies have only recently begun to be applied to psychiatric disorders, and therefore their potential impact is only now being realised (Baron & Rainer, 1988; Whatley eta!, 1988) . However, the fact that the linkage approach with DNA markers enables researchers to track down genes for disorders of largely unknown aetiology and pathogenesis makes this strategy particularly well suited to the study of the major psychoses.
Medical models
DNA markers, or more specifically, restriction fragment length polymorphisms (RFLPs) are generated by cutting DNA with enzymes (endonucleases).
The recognition sites for these enzymes vary harmlessly between individuals, reflecting differences in the base-pair sequence of the DNA. As a result, cutting the DNA of different individuals produces characteristically different lengths of DNA. Such variations are inherited in a simple Mendelian fashion. They can therefore be used as identification tags, so that if a disease can be linked to a marker RFLP, then a susceptibility gene for the disease must lie nearby on the same chromosome. In this way researchers have traced mutant genes through families, and determined, for example, that the genes for cystic fibrosis and Huntington's disease lie on chromosomes 7 and 4 respectively. Once the approximate chromosomal location is known, then a variety of other techniques (see Baron & Rainer, 1988) can be used to identify the precise site and sequence of the gene, and indeed characterise the protein it produces. Reviews of these techniques are available elsewhere (Weatherall, 1985; Gurling, 1985; Davies, 1986 ).
Huntington's disease has served as a prototype for research into single-gene disorders. Gusella et a! (1983) demonstrated linkage to a marker on chromosome 4. Now the location of the defective gene is known with sufficient precision to allow reliable pre-symptomatic diagnosis of individuals â€˜¿ at risk' (Wasmuth et a!, 1988) . It is only a matter of time before the defective gene is isolated, sequenced, and its product identified; at this point, where linkage studies are superseded by sequencing, research into aetiology becomes research into pathogenesis. It is, of course, true that several features of Huntington's disease expedited its tight linkage. The disease was known to be a discrete homogeneous entity, and both the mode of transmission (autosomal dominant) and penetrance (100%) were established.
Thus, the confounding problem of genetic heterogeneity in different families was absent, and two of the parameters that must be estimated in most computer linkage programs could be accurately determined.
The mode of transmission of the common organic and functional psychoses is obviously quite different from that of Huntington's disease and other single gene disorders. However, it is not so different from that in other common disorders with a genetic component, such as the familial cancers, coronary heart disease, or diabetes, which do not show simple Mendelian patterns of inheritance (Bock & Collins, 1987; Scott, 1987) . The aetiology of such dis orders has been regarded as multifactorial.
Thus, Gottesman & Shields (1972) conceptualised schizo phrenia as a multifactorial polygenic disorder, and this was widely accepted as a means of correctly expressing the risk to relatives and of estimating approximate heritability. The disadvantage of such models is that, while they are hard to fault statistically, they do not provide any biological insight into the nature or number of genes involved in a disease or their mechanism of action. It is now clear that the new DNA technologies provide the means to dissect the statistical concept of 591
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Coronary heart disease, the multifactorial disease in which most progress has been made, provides a model of how genetic variance in liability to such a disorder can be broken into its constituent parts. One of the first components to be characterised was familial hypercholesterolaemia â€"¿ individuals heterozygous for the causal gene have twice the normal level of circulating low-density lipoprotein, and in consequence are prone to heart attacks early in adult life (Davis, 1987) . Although this gene devastates the affected families, it accounts for only a small proportion of heart attacks in the population. In general, more subtle genetic variations are the rule, and researchers are now well on their way to assessing the relative importance of genes coding for (a) apolipoproteins, (b) lipoprotein receptors, (c) the enzymes which regulate cholesterol synthesis, and (d) high levels of fibrinogen. Thus the â€˜¿ polygenes' of this multifactorial disorder are gradually being identified (Bock & Collins, 1987) .
Familial Alzheimer's disease and chromosome21
Alzheimer's disease was the first major psychiatric disease to attract the attention of molecular geneti cists. This interest was aroused by the observation that individuals with Down's syndrome who survive into early middle age develop a dementia whose neuropathology is identical to that of Alzheimer's disease (Oliver & Holland, 1986) . The fact that chromosome 21 is triplicated in Down's syndrome provided a strong clue that a putative mutant gene for Alzheimer's disease might be sited here. In some families, Alzheimer's disease segregates as an autosomal dominant disorder, and, in four such families, St George-Hyslop et a! (1987) showed linkage with DNA markers on the proximal part of the long arm of chromosome 21. This was demonstrated by a lod score of 4.25 â€"¿ a score of 3 or above is conventionally taken as proof of linkage. Further excitement followed the demonstration that the gene for the beta amyloid found in the plaques of Alzheimer's disease was in this region, and this was proposed as a â€˜¿ candidate' (or causal) gene. However, it was soon shown that Alzheimer's disease did not segregate exclusively with one allele of the amyloid gene, thus disproving this suggestion (Van Broeckhoven et a!, 1987) .
Several fascinating issues have arisen from the chromosome-2l linkage. Firstly, it is not clear how much of Alzheimer's disease it accounts for; overtly familial cases are no longer thought a minority (Mom et a!, 1987) , and the gene might have such low penetrance that it could explain some apparently sporadic cases. Secondly, it appears that not all familial cases are linked to the chromosome-2l site; there may therefore be genetic heterogeneity (Schellenberg et a!, 1988) . Thirdly, the relationship between genotype and phenotype is not known, but the possibility now exists of exploring cinicogenetic correlates, and of subdividing the condition on the basis of genetic aetiology. In families in whom linkage ha@been demonstrated, Alzheimer's appears to show eady onset and an aggressive course, but this might simply reflect the fact that it is difficult to prove linkage in families where the onset tends to be late. Fourthly, it should be possible to determine the aetiological relationship of Alzheimer's disease to other familial dementias, such as Pick's disease and dementia of frontal type (Neary et a!, 1988) .
Thus, research into Alzheimer's disease is poised for exciting advances, which will have profound clinical implications, and there is an expectation that geneticists will soon reach a similar position with manic depression and schizophrenia.
Genetic heterogeneity in manic depression
Although it is unusual for manic depression to segregate in families as though it results from a single gene, such families do exist, and the absence of father-son transmission in a number of such families led to the idea that a dominant X-linked gene might be involved (Reich et a!, 1969 Totally different, but nonetheless positive, evidence of linkage of bipolar disorder with two markers on the tip of the short arm of chromosome 11 came from a study of the Old Order Amish, a religious community in Pennsylvania (Egeland et a!, 1987) . Since the gene for tyrosine hydroxylase, one of the principal enzymes involved in the synthesis of catecholamines, is located near the markers, this has been proposed as the causal or â€˜¿ candidate' gene, although as yet there is no proof that this is so. Three studies of Icelandic, American and Irish pedigrees (Hodgkinson et a!, 1987; Detera-Wadleigh et a!, 1987; Gill et a!, 1988, respectively) failed to find linkage with the chromosome-Il markers. Since their pedigrees were incompatible with X-linked transmission also, the causal gene(s) in these families must lie elsewhere.
Thus, at least three genetic subtypes of bipolar illness exist, linked to genes on the X chromosome, on chromosome 11, and at another, undetermined site. No family outside the Amish has yet shown the chromosome-li linkage, and it is possible that this mutation is confined to this genetically isolated group. X linkage is likely to be commoner, and indeed Baron et a! (1987) claim that up to 25% of bipolar disorder may be X linked. Nevertheless, the most important task for geneticists is now to locate the gene or genes responsible for the subtype of manic depression not linked to the X chromosome or chromosome ii, which is likely to constitute the majority of cases.
The fact that at least three genes can cause manic depression is much less surprising to geneticists than it is to psychiatrists. While some of the latter have tended to consider that all cases of manic depression, or, even more curiously, that all cases of functional psychosis will have the same underlying cause, the former have become accustomed to apparently discrete clinical disorders breaking down into a variety of molecular pathologies. One such example is retinitis pigmentosa, which is now known to exist in X-linked and autosomal dominant and recessive forms. It may well be that vulnerability to manic depression will turn out to be the result of a biochemical abnormality in some final common pathway, and that a variety of genetically induced enzyme defects can produce this.
Paradoxically, an opposite tendency seems to occur â€"¿ a range of diagnostic categories are found in the pedigrees that have generated the positive linkage results. The rationale for including such phenotypes as unipolar illness and schizoaffective disorder in these analyses is that these conditions occur frequently in the relatives of probands with bipolar illness (Gershon eta!, 1982) . What is striking, however, is that broadening the diagnostic categories to include such individuals as affected cases raises the lod score, i.e. the measure of linkage to the specific gene under consideration. One would have expected the lod score to fall or at most to remain constant if these cases were not genetically linked to the mutant gene, as such individuals would be scored as recombinants. However, in the Amish study, the best evidence for linkage was obtained when those considered as cases included not only bipolar individuals but also those with unipolar major depression and schizoaffective disorder; similarly, the study of Mendlewicz et a! (1987) shows linkage to bipolar, unipolar, and cyclothymic phenotypes.
Localisatlonof a gene for familial schizophrenia
Most experts (e.g. Sturt & McGuffin, 1985; Kendler, 1987) had considered that it would be difficult, if not impossible, to establish linkage in schizo phrenia, not only because of the inevitable diag nostic problems and possible heterogeneity, but also because of the decreased reproduction by ill individuals and the rarity of large multiply affected families.
However, the situation was changed radically by an astute observation by clinicians in Vancouver (Bassett et a!, 1988), who ascertained not only the occurrence of schizophrenia in a Chinese proband and his maternal uncle, but also that these two had different facial features to all other members of the family. Further investigation revealed that they shared several minor physical anomalies, as well as a partial trisomy of chromosome 5, i.e. an extra segment from chromosome 5 was inserted into the long arm of chromosome I. The proband's mother had a balanced translocation, in that she had the same extra segment in chromosome 1 but had lost equivalent material from chromosome 5; thus she had no triplicated genes, and no psychosis. Bassett et a! (1988) suggested that if extra chromosomal material from the translocation site on chromosome 5 could cause schizophrenia, then this was â€˜¿ a candidate region'.
Studies from large American laboratories (e.g. Kennedy et a!, 1988) failed to find any linkage between schizophrenia and DNA markers in the crucial segment, and it began to look as if Bassett's hypothesis was mistaken. However, DeLisi et a! (1988), who used the glucocorticoid receptor gene as a marker, reported preliminary results that did suggest possible linkage. Subsequently, Sherrington eta! (1988) reported striking positive results; linkage was demonstrated with a high degree of statis tical certainty between schizophrenia and two chromosome 5 probes in two English and five Icelandic pedigrees. In these families schizophrenia appeared to be inherited as an autosomal dominant condition with high penetrance, and out of 104 family members at risk, 39 had developed schizo phrenia.
The researchers evaluated several models of transmission on their data, and those assuming dominant inheritance with high (86%) penetrance gave the highest lod score. Such a mode of transmission cannot account for all schizophrenia (O'Rourke et a!, 1982) , and even the protagonists of dominant transmission have assumed much lower penetrance; Karlsson (1988) , for example, assumed 25%. It would not be surprising if the pedigrees in this study turned out to be atypical, for they were chosen because they did appear to show Mendelian transmission. There are two obvious possibilities. This could be an unusual dominant disorder, and its relationship to schizophrenia as a whole akin to that of familial hypercholesterolaemia to coronary artery disease. Alternatively, these families might be atypical only in showing high penetrance of the gene, and dominant transmission with low penetrance could be the general rule.
Assuming that other studies also show this linkage, we can draw a number of conclusions about the aetiology of schizophrenia. Firstly, the arguments of those who dispute a genetic contribution can be finally dismissed. Secondly, it appears that classic schizophrenia is only one of a spectrum of disorders that can arise from a mutant gene on chromosome 5. This is shown by the fact that expanding the diagnostic categories to include schizophrenia spectrum disorders, and indeed minor depression and alcoholism, as affected cases increased the lod score to 6.49. What is coded for in the mutant allele cannot, therefore, be schizophrenia per Se, but the predisposition to develop schizophrenic psychosis and related non-psychotic illness and personality disorder. This is, of course, a similar pattern to that which emerged from the families of probands with manicâ€"depressiveillness.
Conclusions
Traditionally, nosologists have had to rely primarily on phenotypic characteristics (e.g. phenomenology and course of illness) to classify psychiatric disorder; indeed, systems such as DSMâ€"III (American Psychiatric Association, 1980) make a virtue out of eschewing aetiological considerations. It is now clear that the same phenotype, even when based on strict operational criteria, can be the result of several distinct chromosomal lesions, i.e. several genotypes have the same phenotype. Conversely, one genotype can be associated with the development of a diverse array of psychiatric conditions. The study of Sherrington et a! (1988) suggests that, in some families at least, schizophrenia is aetiologically related to unipolar depression, alcoholism, and personality disorder. The implications for our understanding of the pathogenesis of such conditions are that we have to explain how there is divergence from a single genotype to several phenotypes, and convergence from several genotypes to a single phenotype.
The fact that already three different genetic causes of manic depression and one of schizophrenia, to say nothing of environmental causes, are known to exist, means that nostalgic notions of unitary psychosis (Crow, 1986) can be laid to rest. Indeed, although a divergence of genotypic expression exists, classic schizophrenia and manic depression have not been shown to coexist as a result of a common genetic defect. This may be an ascertainment artefact, since families have tended to be chosen for the preponderance of a particular psychosis. An interesting exercise, therefore, would be to run chromosome 5, X and 11 probes through families containing a mixture of schizophrenic and manic depressive relatives, and where no assortative mating had occurred.
The â€˜¿ new genetics' tell us that defects at single major loci tend to predispose an individual to the development of only one of the major psychoses, with the exception of schizoaffective disorder, whose status remains unclear. The pattern emerging is one of discrete genetic lesions predisposing a core of family members with the defect to the same psychotic illness; other members of the family with the defective gene can develop related minor disorders, such as unipolar depression and personality disorder, but what they do not tend to develop, in the families studied so far, are psychotic illnesses far removed from the core diagnosis. It seems that we are about to move into a period when genetics will define disease entities in psychiatry; while genetics does not agree with any of the operationalised diagnostic systems worked out so industriously over the past 20 years, neither does it agree with alternative proposals, such as the einheitpsychose.
It is not surprising that aetiological heterogeneity is revealed when molecular genetic techniques are applied to diagnostic end points such as manic depression. So far, the main approach used in psychiatry has been gene mapping, with identifi cation of the responsible gene(s) as the most important goal. It is likely that, once the gene is identified, sequenced and its protein characterised, even for a very uncommon variant, this will tell us a very great deal about the pathogenesis of the more common varieties, for it seems likely that more common causes will act through similar patho genetic mechanisms. Certainly this has been the pattern in coronary heart disease, with familial *Correspondence hypercholesterolaemia, rare though it is, providing important insights into mechanisms of degenerative vascular disease.
Even before the genes themselves are identified, it is likely that allelic markers will be found sufficiently close for their reliable use in predicting genetic risk of individuals, or in differential diagnosis. Not only will we be able to do population studies with greater confidence, but the demand for genetic counseffing will inevitably grow.
